MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive
Running out mid-protocol means starting the titration process over, which wastes time and money
Storage, Handling, and Stability Guidelines Your work isnt finished once the peptide is dissolved
The impact of different comorbidities on proarrhythmic mechanisms is increasingly recognized as well
Unlike the New Technology APC low volume policy, the universal low volume APC policy applies to clinical APCs and brachytherapy APCs, in addition to procedures assigned to New Technology APCs, and uses the highest of the geometric mean, arithmetic mean, or median based on up to 4 years of claims data to set the payment rate for the APC